Amylin (8-37), human;ATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2

Amylin (8-37), human;ATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2

135702-23-7

C₁₃₈H₂₁₆N₄₂O₄₅

atqrlanflvhssnnfgailsstnvgsnty-nh2 ; h-ala-thr-gln-arg-leu-ala-asn-phe-leu-val-his-ser-ser-asn-asn-phe-gly-ala-ile-leu-ser-ser-thr-asn-val-gly-ser-asn-thr-tyr-nh2 ; amylin (8-37) (human) ; human amylin 8-37 ; amylin fragment 8-37 amide ; l-alanyl-l-threonyl-l-glutaminyl-l-arginyl-l-leucyl-l-alanyl-l-asparaginyl-l-phenylalanyl-l-leucyl-l-valyl-l-histidyl-l-seryl-l-seryl-l-asparaginyl-l-asparaginyl-l-phenylalanylglycyl-l-alanyl-l-isoleucyl-l-leucyl-l-seryl-l-seryl-l-threonyl-l-asparaginyl-l-valylglycyl-l-seryl-l-asparaginyl-l-threonyl-l-tyrosinamide ; humanamylin 8-37 ; amylin fragment 8-37 human ; diabetes associated peptide fragment 8-37 amide ; l-tyrosinamide,l-alanyl-l-threonyl-l-glutaminyl-l-arginyl-l-leucyl-l-alanyl-l-asparaginyl-l-phenylalanyl-l-leucyl-l-valyl-l-histidyl-l-seryl-l-seryl-l-asparaginyl-l-asparaginyl-l-phenylalanylglycyl-l-alanyl-l-isoleucyl-l-leucyl-l-seryl-l-seryl-l-threonyl-l-asparaginyl-l-valylglycyl-l-seryl-l-asparaginyl-l-threonyl-(9ci) ; ala-thr-gln-arg-leu-ala-asn-phe-leu-val-his-ser-ser-asn-asn-phe-gly-ala-ile-leu-ser-ser-thr-asn-val-gly-ser-asn-thr-tyr-nh2